New IARC Brief Highlights Benefits of Single Dose HPV Vaccine

A new brief from the International Agency for Research on Cancer (IARC) adds further momentum to movements recommending a single dose of the HPV (human papillomavirus) vaccine.  Originally recommended as a three-dose series when first approved and made widely available, the CDC currently recommends two doses of the HPV vaccine for 9 – 14 year […]